Publisher
Springer Science and Business Media LLC
Reference27 articles.
1. Aflorei ED, Korbonits M. Epidemiology and etiopathogenesis of pituitary adenomas. J Neurooncol. 2014;117(3):379–94. https://doi.org/10.1007/s11060-013-1354-5.
2. Daly AF, Rixhon M, Adam C, Dempegioti A, Tichomirowa MA, Beckers A. High prevalence of Pituitary adenomas: a cross-sectional study in the Province of Liège, Belgium. J Clin Endocrinol Metabolism. 2006;91(12):4769–75. https://doi.org/10.1210/jc.2006-1668.
3. Khamseh ME, Tehrani MRM, Mousavi Z, Malek M, Imani M, Tehrani NH, et al. Iran pituitary tumor registry: description of the program and initial results. Arch Iran Med. 2017;20(12):746–51.
4. Araujo-Castro M, Berrocal VR, Pascual-Corrales E. Pituitary tumors: epidemiology and clinical presentation spectrum. Hormones. 2020;19(2):145–55. https://doi.org/10.1007/s42000-019-00168-8.
5. Ezzat S, Asa SL, Couldwell WT, Barr CE, Dodge WE, Vance ML, et al. The prevalence of pituitary adenomas: a systematic review. Cancer: Interdisciplinary Int J Am Cancer Soc. 2004;101(3):613–9.